TwinBeech Capital’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.45M Buy
+13,646
New +$1.65M 0.26% 117
2026
Q1
Sell
-44,009
Closed -$7.66M 694
2025
Q4
$7.66M Buy
+44,009
New +$8.03M 0.54% 52
2023
Q2
Sell
-248,667
Closed -$4.24M 727
2023
Q1
$4.24M Buy
+248,667
New +$4.83M 0.09% 257
2022
Q4
Sell
-106,031
Closed -$2.28M 796
2022
Q3
$2.28M Buy
+106,031
New +$2.54M 0.06% 313
2022
Q2
Sell
-34,026
Closed -$800K 604
2022
Q1
$800K Buy
+34,026
New +$791K 0.04% 348
2021
Q1
Sell
-15,811
Closed -$526K 548
2020
Q4
$526K Buy
+15,811
New +$578K 0.09% 276
2020
Q1
Sell
-14,509
Closed -$346K 379
2019
Q4
$346K Buy
+14,509
New +$295K 0.1% 271

Other funds holding INSM

TwinBeech Capital's INSM Position: Q2 2026 in Review

TwinBeech Capital opened a new position in Insmed (INSM) in Q2 2026: 13,646 shares worth $1.45M. The stake represents 0.26% of the portfolio and ranks #117 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in INSM as recently as Q4 2025.

TwinBeech Capital first reported a position in INSM in Q4 2019 and has held it in 7 quarters since. The position peaked at $7.66M in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • TwinBeech Capital held 13,646 shares of Insmed worth $1.45M as of Q2 2026.
  • Insmed was a new TwinBeech Capital position in Q2 2026.
  • Insmed made up 0.26% of TwinBeech Capital's portfolio in Q2 2026, its #117 holding.
  • TwinBeech Capital first reported a position in Insmed in Q4 2019 and has held it in 7 quarters since.
  • TwinBeech Capital's Insmed position peaked at $7.66M in Q4 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.